Individualized Treatment Is Needed for mCRC Subset
CURE spoke with Maria Ignez Braghiroli, M.D. about the need for individualized treatment for patients with NRAS-mutant metastatic colorectal cancer.
Discussing the World Health Organization's New Brain Tumor Classification
The World Health Organization (WHO) reclassified some types of brain cancers, giving a clearer outline on how to treat them.
Comparing Treatments in Breast Cancer Subsets
Sibylle Loibl, M.D., Ph.D., discusses the GeparSepto trial and what it means for women with breast cancer.
Expert Discusses What Advances to Expect in Liver Cancer
Michael Choti talks about what kind of advances can be expected in treating liver cancer, including PD-1 inhibitors and neoadjuvant treatment.
4 Questions With a Surgeon: How to Improve Treatment of Glioblastoma
More advances, such as personalized approaches, still need to be made in treating glioblastoma, says Jennifer Moliterno Gunel, a brain surgeon from Yale.
3 Questions: The Impact of Tecentriq to Treat Patients With Advanced Bladder Cancer
Tecentriq (atezolizumab) has been found to be non-toxic and has demonstrated a major survival advantage in patients with metastatic urothelial bladder cancer.
5 Questions With a Physician on Improving Treatment of Pancreatic Cancer
Eileen O'Reilly discusses the current barriers in treating pancreatic cancer, as well as what she sees for the future of the disease.
Physician Discusses Connection Between Early Tumor Shrinkage and Survival in Colorectal Cancer
Volker Heinemann says early tumor shrinkage may be a better predictor than progression-free survival in colorectal cancer.
Nintedanib, Immunotherapy: Physician Looks Ahead in Treatment of Colorectal Cancer
CURE spoke with Axel Grothey about advances in the treatment of colorectal cancer.
Multigene Panel Testing Could Reveal Breast and Ovarian Cancer Risks
Allison W. Kurian offers insight on using multigene panel testing to discover breast and ovarian cancer risks that may have otherwise went undetected.
Abemaciclib Looks Promising in Breast Cancer Subset Ahead of Phase 3 Trial
A phase 2 study showed that abemaciclib may be a promising option for some patients with breast cancer.
Expert Reviews Importance of BRCA Testing in Ovarian Cancer
Testing for BRCA mutations is an important step in developing the treatment plan for patients with breast cancer, says Leslie Randall.
Exploring the Next Steps for Immunotherapy in Kidney Cancer
What are the next steps for immunotherapy in RCC? CURE spoke with Mark Ball to find out.
Role of Radiation Continues to Change in Elderly Patients With Breast Cancer
The role of radiation continues to change for patients with breast cancer, especially for those over the age of 70, for whom radiation might not be the best option.
Analyzing the Present and Future of Immunotherapy for Melanoma
Many advances have been made regarding immunotherapy to treat melanoma, and there is also more to come, says Antoni Ribas.
PARP Inhibitor's Approval Could Expand to Include Ovarian Cancer Patients Without BRCA Mutation
Phase 3 studies are giving investigators hope that Lynparza (olaparib) will gain FDA approval for the treatment of ovarian cancer, according to Ursula A. Matulonis.
Use of Immunotherapy Could Grow to All NSCLC Settings
Immunotherapy for the treatment of NSCLC will eventually be used in all settings, according to Edward Kim.
Global Lung Cancer Coalition Fighting Disease on an International Level
Changing the Face of Brain Cancer, One Patient at a Time
With dedication to research and advocacy, the National Brain Tumor Society is making strides in treatment of brain cancer.
LUNGevity Allows Patients With Lung Cancer to Breathe Easy
Personalizing Care for Children With Medulloblastoma
The coming years look promising for advances in treatment of pediatric brain cancer, according to Matthias A. Karajannis.
Striving to Answer the Big Questions in Brain Cancer Care
Andrew S. Chi discusses some of the exciting new advancements for treatment of brain cancer.
2 Clarke Drive Cranbury, NJ 08512